Tomoya Muto

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 5

Top Venues

Leukemia

This page only lists publications with an associated author ORCID identifier.

Publications

Shinichiro Matsui, Chihiro Ri, Lyndsey C Bolanos, Kwangmin Choi, Asuka Shibamiya, Arata Ishii, Koji Takaishi, Nagisa Oshima-Hasegawa, Shokichi Tsukamoto, Yusuke Takeda, Naoya Mimura, Akihide Yoshimi, Koutaro Yokote, Daniel T Starczynowski, Emiko Sakaida, Tomoya Muto
Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression. Leukemia 38 (5) (2024)
Shinichiro Matsui, Chihiro Ri, Lyndsey C Bolanos, Kwangmin Choi, Asuka Shibamiya, Arata Ishii, Koji Takaishi, Nagisa Oshima-Hasegawa, Shokichi Tsukamoto, Yusuke Takeda, Naoya Mimura, Akihide Yoshimi, Koutaro Yokote, Daniel T Starczynowski, Emiko Sakaida, Tomoya Muto
Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression. Leukemia 38 (5) (2024)
Shinichiro Matsui, Chihiro Ri, Lyndsey C Bolanos, Kwangmin Choi, Asuka Shibamiya, Arata Ishii, Koji Takaishi, Nagisa Oshima-Hasegawa, Shokichi Tsukamoto, Yusuke Takeda, Naoya Mimura, Akihide Yoshimi, Koutaro Yokote, Daniel T Starczynowski, Emiko Sakaida, Tomoya Muto
Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression. Leukemia (2024)
Shinichiro Matsui, Chihiro Ri, Lyndsey C Bolanos, Kwangmin Choi, Asuka Shibamiya, Arata Ishii, Koji Takaishi, Nagisa Oshima-Hasegawa, Shokichi Tsukamoto, Yusuke Takeda, Naoya Mimura, Akihide Yoshimi, Koutaro Yokote, Daniel T Starczynowski, Emiko Sakaida, Tomoya Muto
Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression. Leukemia 38 (5) (2024)
Shinichiro Matsui, Chihiro Ri, Lyndsey C Bolanos, Kwangmin Choi, Asuka Shibamiya, Arata Ishii, Koji Takaishi, Nagisa Oshima-Hasegawa, Shokichi Tsukamoto, Yusuke Takeda, Naoya Mimura, Akihide Yoshimi, Koutaro Yokote, Daniel T Starczynowski, Emiko Sakaida, Tomoya Muto
Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression. Leukemia 38 (5) (2024)

Tomoya Muto.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tomoya Muto